Navigation Links
Pharmacyclics Reports First Quarter 2013 Results
Date:5/1/2013

ter ended March 31, 2012, GAAP net loss was $12.8 million, or $0.19 loss per share. This includes stock-based compensation expense of $3.5 million.

The increase of the stock-based compensation expense to $23.6 million for the three months ended March 31, 2013 compared to $3.5 million for the three months ended March 31, 2012 was primarily related to the timing and accounting of grants for performance-based stock options, share price appreciation and the growth in the Company's employee base.  For the remainder of 2013 the Company expects stock-based compensation expense to average $18 million to $22 million per quarter.

GAAP operating expenses were $55.8 million for the quarter ended March 31, 2013, compared to $19.9 million for the quarter ended March 31, 2012. No Excess Amounts were recognized as a reduction to operating expenses for the three months ended March 31, 2013 and 2012.

As of March 31, 2013, the Company had cash, cash equivalents and marketable securities of $511.2 million, compared with $317.1 million as of December 31, 2012. As previously announced, during the three months ended March 31, 2013, the Company sold 2.2 million shares of its common stock in an underwritten public offering for net proceeds of $201.0 million. The net proceeds from the public stock offering were received during the three months ended March 31, 2013.

As previously disclosed in our earnings release for the quarter ended December 31, 2012, the Company expected to end the calendar year 2013 with cash, cash equivalents and marketable securities of more than $225 million. With net proceeds of $201 million from the underwritten public offering and additional milestones expected to be earned during the calendar year, the Company now expects to end 2013 with approximately $500 million in cash, cash equivalents, marketable securities and receivables due from our collaboration partner.

To date, the Company has earned four milestone payments unde
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
2. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
3. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
4. Pharmacyclics, Inc. Prices Public Offering of Common Stock
5. Pharmacyclics, Inc. Announces Proposed Public Offering of Common Stock
6. Pharmacyclics First to Announce Breakthrough Therapy Designation in Oncology from the U.S. Food and Drug Administration
7. Pharmacyclics Announces Date of Financial Results for Three and Six Months Ended December 31, 2012 and Conference Call
8. Pharmacyclics Reports Fourth Quarter and Full Year Fiscal 2012 Financial Results and Recent Developments
9. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
10. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
11. Hospira Reports First-Quarter 2013 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014  IGI Laboratories, Inc. ... the closing of its offering of $125 million aggregate ... (the "Notes").  The Notes were offered and sold only ... the Securities Act of 1933, as amended (the "Securities ... fixed rate of 3.75% per year, payable semiannually in ...
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... of the "MEMS Gyroscopes Analog Devices ADIS16136 ... report to their offering. ... tactical grade applications made a lot of progress ... reliability. They are now accepted in high-reliability environments, ...
(Date:12/15/2014)... and HERZLIYA PITUACH, Israel , Dec. ... IMNP ) announced today that its Board of ... succeeding Dr. Daniel Teper who continues as Chief ... of Immune,s Board of Directors since 2013. Immune,s ... delighted to represent the interest of shareholders and to continue ...
Breaking Medicine Technology:IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4
... Retirement Living TV (RLTV), the only network dedicated to ... Body Health on Thursday, November 19(th) at 8:00 pm ... to the center of public policy, award-winning medical journalist Kevin ... and advice tied to complementary and integrative medicine. He ...
... , WOODCLIFF LAKE, N.J., Nov. 16 Par Pharmaceutical ... Day from 9:00am to 12:00pm EST on December 3, 2009 at ... Executive Officer, Patrick G. LePore, and other members of the senior ... current products and pipelines, and business outlook to analysts and investors. ...
Cached Medicine Technology:Retirement Living TV Premieres Season Two of Whole Body Health 2
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... the U.S. Agency for International Development (USAID), is providing an ... This assistance is in addition to the $4 million ... in Zimbabwe. , , "Before ... to prepare for the possibility of an outbreak in Zimbabwe. ...
... OF PRUSSIA, Pa., Dec. 4 Universal Health,Realty Income Trust ... expanded their,Board of Trustees with the appointment of Marc D. ... Mr. Miller brings to UHT,more than 13 years of experience ... Vice President and Co-head of the Acute Care Division,since 2007 ...
... December 4, 2008) - An Ontario study of ... small proportion, 19%, were referred for genetic testing of ... family members are not informed of their cancer risk. ... the University of Toronto,s Lawrence S. Bloomberg Faculty of ...
... sickle-cell disease and thalassemia , ... ... ( www.childrenshospital.org ) and Dana-Farber Cancer Institute have identified a ... of hemoglobin normally made only before birth or by young ...
... Dec. 4 NAMC members can gain access to cutting ... and opportunities for interaction via computer. The next webinar ... Finding and Communicating With Your Online Audience , ... Once you,ve found them, do you know how to engage ...
... Dr. Stephen Joffe, Craig Joffe, and,Alan Buckey today filed ... and Exchange Commission. The group previously filed a ... LCAV ), which,operates 77 LasikPlus fixed-site laser vision ... Dr. Joffe is the founder and former Chairman and ...
Cached Medicine News:Health News:USAID Increases Assistance for Zimbabwe Cholera Outbreak 2Health News:Few Ontario women with invasive ovarian cancer referred for genetic testing of breast cancer genes 2Health News:Turning back the Clock in Inherited Anemias 2Health News:Turning back the Clock in Inherited Anemias 3Health News:Turning back the Clock in Inherited Anemias 4Health News:New NAMC Member Service! Complimentary Webinars for NAMC Members - On Topics You Need to Know! Sign Up Today for This New and Exciting Educational Program! 2Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 2Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 3Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 4Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 5Health News:11.4% Shareholders & Former Executive Management of LCA-Vision Seek Board Representation and Executive Management Positions 6
Shafts angled 45 degrees, 10 mm from tip to bend. 1 x 2 teeth. Serrated handle with polished finish. Most popular size or model....
Shafts angled 45 degrees, 10 mm from tip to bend. Tips curved with 0.5 mm, 1 x 2 teeth. Serrated handle with polished finish....
Straight shafts with 5.5 mm tying platform and 1 mm crisscross serrated tips. Wide serrated handle with polished finish....
Smooth pointed tips open to 3.0 mm. Cross action curved shafts. Tip to Angle Length: 12.0 mm. Round handle....
Medicine Products: